February

Movers and Shakers February 2017

 Ex-Novartis CEO Joins Flagship Pioneering Former CEO of Novartis Pharmaceuticals, David Epstein joins Flagship ...

My Other Life with Geeta Padbidri

PM360 recently spoke to Geeta Padbidri, former Director of Commercial Strategy & Analytics at ...

An Enormous Wasted Opportunity—Packaging

I can make almost any patient take their medication as directed. It isn’t hard, ...

Off-label Guidance Finally Arrives

In January, the FDA released its long-anticipated draft guidance, regarding promotion of a medication’s ...

Rebuilding Value—It’s Critical to Survival

While the pharmaceutical industry makes great strides toward innovating “silver bullet” therapies for various ...

5 Commercialization Hacks for a Rare Disease Treatment

When it comes to commercializing rare disease products, there are no shortcuts to success. ...

How Prognos is Using AI to Track and Predict Disease and Identify Patients Early On

Back in 2010, Sundeep Bhan, an eHealth entrepreneur who previously lead Medsite before its ...

CES Reveals the Near Future of Tech

The annual Consumer Electronics Show (CES) in Las Vegas kicks off the New Year ...

Industry Briefs February 2017

CVS Offers Low-cost Generic EpiPen CVS, the largest drug-store chain in the U.S., has ...